Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings?

Key Takeaways HOLX's GYN Surgical revenues rose 10.2% to $172.5M last quarter, led by MyoSure, Fluent and Gynesonics.HOLX's Surgical outlook is supported by forecast 8.8% revenue growth versus last year, per consensus.Hologic sees adoption outside the U.S. rise as new reimbursement lifts NovaSure and MyoSure growth.Hologic’s (HOLX) GYN Surgical business is benefiting from a mix of internal innovation and product line additions through M&A, positioning it as a meaningful growth driver. The portfolio includes ...